Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 rollover study of cenicriviroc for liver fibrosis in nonalcoholic steatohepatitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of Ifetroban for portal hypertension in cirrhotic patients has completed with results p…
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication [Phase 3]
A Phase 3 clinical trial evaluating integrated traditional Chinese and clinical medicine for chronic hepatitis B and its complications is un…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency [Phase 2]
Phase 2 trial investigating carbamazepine for severe liver disease due to Alpha-1 antitrypsin deficiency was terminated; results posted late…
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Anticoagulation Therapy After Splenectomy in Cirrhosis Patient [Phase 1, Phase 2]
A clinical trial evaluating anticoagulation therapy after splenectomy in patients with liver cirrhosis and portal hypertension has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors) [Phase 4]
Phase 4 trial update on proton pump inhibitors for patients with liver cirrhosis, hypertension, and portal conditions; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients [Phase 4]
Phase 4 trial assessing the impact of entecavir on regression and outcomes in patients with HBV-related liver fibrosis and cirrhosis.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Mesenchymal Stem Cell Therapy for Liver Cirrhosis [Phase 1, Phase 2]
A clinical trial update on mesenchymal stem cell therapy for liver cirrhosis across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis [Phase 4]
Phase 4 clinical trial updating the efficacy and safety of anticoagulant therapy in patients with portal vein thrombosis and liver cirrhosis…
-
FDA approval · 2021-01-27FDA Approved: FUROSEMIDE — Original Application (Sagent Pharmaceuticals)
FDA approved a new generic version of furosemide from Sagent Pharmaceuticals under an original application, enabling market entry as a loop …
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis [Phase 3]
Phase 3 trial update on supplemental corticosteroids in cirrhotic hypotensive patients with suspected sepsis; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence [Phase 2]
Phase 2 trial evaluating pravastatin to delay recurrence of hepatocellular carcinoma in patients with liver cirrhosis was terminated; result…
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis [Phase 3]
Phase 3 clinical trial update for autologous endothelial progenitor cell therapy aimed at reversing liver cirrhosis in end-stage liver disea…
-
FDA approval · 2020-12-22FDA Approved: FUROSEMIDE — Supplemental Application (Marlex Pharmaceuticals, Inc.)
The FDA approved a supplemental application for furosemide from Marlex Pharmaceuticals, Inc., indicating an additional/or updated approval f…
-
FDA approval · 2020-12-02FDA Approved: METOLAZONE — Original Application (Alembic Pharmaceuticals Limited)
Alembic Pharmaceuticals Limited's original application for metolazone received FDA approval, enabling the generic version to be marketed in …
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis [Phase 3]
Phase 3 trial update of glecaprevir/pibrentasvir in treatment-naive adults with chronic HCV infection (genotypes 1-6) and compensated cirrho…
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis [Phase 2, Phase 3]
A combined therapy of a proton pump inhibitor with propranolol was studied against PPI alone for healing peptic ulcers in patients with live…
-
FDA approval · 2020-05-04FDA Approved: TORSEMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Torsemide from Rising Pharma Holdings, Inc. under an ANDA (ANDA078249).
-
FDA approval · 2020-05-04FDA Approved: TORSEMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for torsemide from Teva Pharmaceuticals USA, Inc., under the Torsemide product line.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial. [Phase 4]
A phase 4 randomized, single-blinded trial assessing the hemodynamic profile of terlipressin and octreotide in patients with liver cirrhosis…
-
FDA approval · 2020-04-06FDA Approved: BUMETANIDE — Supplemental Application (NorthStar Rx, LLC)
The FDA approved a supplemental application for bumetanide submitted by NorthStar Rx, LLC.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC [Phase 4]
Phase 4 trial comparing cefotaxime, ceftriaxone, and ciprofloxacin for spontaneous bacterial peritonitis in patients with liver cirrhosis.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Pregabalin Against Frequent Muscle Cramp in Patients With Liver Cirrhosis [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of pregabalin for treating frequent muscle cramps in patients with liver cirrhosis; study …
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver Disease [Phase 1, Phase 2]
A clinical trial assessing co-transfer of mesenchymal stem cells and regulatory T cells for end-stage liver disease is in Phase 1/Phase 2 wi…
-
FDA approval · 2020-02-19FDA Approved: ETHACRYNIC ACID — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith's original generic application for Ethacrynic acid, a loop diuretic.